カテゴリ： MarketLine, アメリカ, 企業調査

Cleco Corporate Holdings, LLC：戦略・SWOT・企業財務分析

◆英語タイトル：Cleco Corporate Holdings, LLC - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8015396
◆発行会社（調査会社）：MarketLine
◆発行日：2017年9月30日
◆ページ数：47
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：エネルギー・装置
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Cleco Corporate Holdings, LLC – Strategy, SWOT and Corporate Finance Report
Summary

Cleco Corporate Holdings, LLC – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Cleco Corporation (Cleco or ‘the company’) is a utility holding company that is engaged in the businesses of regulated electric utility and wholesale energy. The company primarily operates in the US, where it is headquartered in Pineville, Louisiana and employed 1,207 people as on December, 31 2015.

Scope

- Detailed information on Cleco Corporate Holdings, LLC required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Cleco Corporate Holdings, LLC in the form of a SWOT analysis
- An in-depth view of the business model of Cleco Corporate Holdings, LLC including a breakdown and examination of key business segments
- Intelligence on Cleco Corporate Holdings, LLC’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Cleco Corporate Holdings, LLC, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Cleco Corporate Holdings, LLC and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Cleco Corporate Holdings, LLC as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Cleco Corporate Holdings, LLC’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Cleco Corporate Holdings, LLC: Company Overview
Cleco Corporate Holdings, LLC: Overview and Key Facts
Cleco Corporate Holdings, LLC: Overview
Cleco Corporate Holdings, LLC: Key Facts
Cleco Corporate Holdings, LLC: Key Employees
Cleco Corporate Holdings, LLC: Key Employee Biographies
Cleco Corporate Holdings, LLC: Major Products and Services
Cleco Corporate Holdings, LLC: Company History
Cleco Corporate Holdings, LLC: Management Statement
Cleco Corporate Holdings, LLC: Locations and Subsidiaries
Cleco Corporate Holdings, LLC: Key Competitors
Cleco Corporate Holdings, LLC: Company Analysis
Cleco Corporate Holdings, LLC: Business Description
Cleco Corporate Holdings, LLC: SWOT Analysis
Cleco Corporate Holdings, LLC: SWOT Overview
Cleco Corporate Holdings, LLC: Strengths
Cleco Corporate Holdings, LLC: Weaknesses
Cleco Corporate Holdings, LLC: Opportunities
Cleco Corporate Holdings, LLC: Threats
Cleco Corporate Holdings, LLC: Corporate Financial Deals Activity
Cleco Corporate Holdings, LLC: Financial Deals Overview
Cleco Corporate Holdings, LLC: Top Deals 2013 – 2017YTD*
Cleco Corporate Holdings, LLC: Advisors
Cleco Corporate Holdings, LLC: Top Legal Advisors
Cleco Corporate Holdings, LLC: Top Financial Advisors
Cleco Corporate Holdings, LLC: Private Equity and Ownership
Cleco Corporate Holdings, LLC: Recent Developments
Cleco Corporate Holdings, LLC: News and Events Summary
Cleco Corporate Holdings, LLC: Business Expansion
Cleco Corporate Holdings, LLC: Contracts
Cleco Corporate Holdings, LLC: Corporate Governance
Cleco Corporate Holdings, LLC: Financial Performance
Cleco Corporate Holdings, LLC: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Cleco Corporate Holdings, LLC: Key Facts
Table 2: Cleco Corporate Holdings, LLC: Key Employees
Table 3: Cleco Corporate Holdings, LLC: Locations and Subsidiaries
Table 4: Cleco Corporate Holdings, LLC: Key Competitors
Table 5: Cleco Corporate Holdings, LLC: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: Cleco Corporate Holdings, LLC: Top Deals 2013 - 2017YTD*
Table 7: Cleco Corporate Holdings, LLC: Legal Advisor Ranking by Value (US$m)
Table 8: Cleco Corporate Holdings, LLC: Financial Advisor Ranking by Value (US$m)
Table 9: Cleco Corporate Holdings, LLC: Private Equity and Ownership Volume and Value Trend (2013 - YTD*2017)
Table 10: Cleco Corporate Holdings, LLC: Private Equity and Ownership Volume by Deal Type (2013 - YTD*2017)
Table 11: Cleco Corporate Holdings, LLC: News and Events Summary
Table 12: Cleco Corporate Holdings, LLC: Business Expansion
Table 13: Cleco Corporate Holdings, LLC: Contracts
Table 14: Cleco Corporate Holdings, LLC: Corporate Governance
Table 15: Cleco Corporate Holdings, LLC: Financial Performance
Table 16: Cleco Corporate Holdings, LLC: Strategy and Operations

★海外企業調査レポート[Cleco Corporate Holdings, LLC：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Biomunex Pharmaceuticals：製薬・医療：M&Aディール及び事業提携情報
    Summary Biomunex Pharmaceuticals (Biomunex) is a biopharmaceutical company that discovers and develops bispecific antibody therapeutics for the treatment of cancer. The company’s portfolio of pipeline products incldes BMX-101, which is developed as a novel immunotherapeutic treatment for relapsed an …
  • Theralase Technologies Inc (TLT)：医療機器：M&Aディール及び事業提携情報
    Summary Theralase Technologies Inc (Theralase Technologies) is a biopharmaceutical company that manufactures, designs, and develops laser and laser technology for companion animal, human, and equine applications. The company offers products such as multiple probe, controller, multiple probe, triple …
  • Vivid Technology Ltd (VIV)：電力：M&Aディール及び事業提携情報
    Summary Vivid Technology Ltd (Vivid Technology), formerly Greenearth Energy Ltd, is a renewable energy company that offers technology services. The company provides geothermal exploration and investment services. It provides services such as custom installation, project management, and lighting effi …
  • Omega Diagnostics Group Plc (ODX)：企業の財務・戦略的SWOT分析
    Summary Omega Diagnostics Group Plc (Omega) is a biotechnology company that provides in-vitro diagnostic products. The company provides products in the areas of allergy, food intolerance, autoimmune disease and infectious disease, among others. It also provides food intolerance and autoimmune tests …
  • Energy XXI Gulf Coast Inc (EXXIQ)：企業の財務・戦略的SWOT分析
    Summary Energy XXI Gulf Coast Inc (Energy XXI) is an oil and gas company that explores and develops oil and natural gas assets. The company’s projects include West Delta, South Timbalier, South Pass, Main Pass, and Ship Shoal. Its West Delta property is located 28 miles offshore of Grand Isle, Louis …
  • Plant Bioscience Ltd-製薬・医療分野：企業M&A・提携分析
    Summary Plant Bioscience Ltd (PBL) is a technology management company that specializes in plant, food and microbial science. The company provides intellectual property management, patent advisory and technology transfer services to life science companies and investors. Its patent consultation and ma …
  • Biomatrica Inc：医療機器：M&Aディール及び事業提携情報
    Summary Biomatrica Inc (Biomatrica) is a developer, manufacturer, and supplier of stability technologies preserve biological materials. The company offers DNA, RNA, proteins, cells, and entire assays for diagnostics, research, forensics, biobanks, and sustainability applications. Its products includ …
  • Western Digital Corp (WDC)：企業の財務・戦略的SWOT分析
    Western Digital Corp (WDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Chico’s FAS Inc：戦略・SWOT・企業財務分析
    Chico's FAS Inc - Strategy, SWOT and Corporate Finance Report Summary Chico's FAS Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Versantis AG：製薬・医療：M&Aディール及び事業提携情報
    Summary Versantis AG (Versantis) is a pharmaceutical company that develops new generation of medicines and diagnostics for treating patients with liver diseases. The company’s pipeline product includes VS-01, a liposomal-based peritoneal dialysis fluid that acts as a clearance enhancer for a large s …
  • Mapfre Middlesea p.l.c.：企業の戦略・SWOT・財務分析
    Mapfre Middlesea p.l.c. - Strategy, SWOT and Corporate Finance Report Summary Mapfre Middlesea p.l.c. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Lietuvos energijos gamyba, AB (LNR1L)-エネルギー分野：企業M&A・提携分析
    Summary Lietuvos energijos gamyba, AB (Lietuvos), a subsidiary of Lietuvos Energija UAB, is a state-controlled electric utility that generates, imports and exports, and supplies electricity and thermal energy. It generates electricity from hydro, thermal and renewable energy sources. The company tra …
  • Premaitha Health Plc (NIPT)-製薬・医療分野：企業M&A・提携分析
    Summary Premaitha Health Plc (Premaitha Health), formerly Vialogy Plc, is a molecular diagnostics company, which focuses on the development of genetic screening tests including novel tests for non-invasive prenatal screening (NIPT). Its flagship product, the IONA test is an advanced NIPT test that a …
  • The Goldman Sachs Group Inc (GS)：企業の財務・戦略的SWOT分析
    The Goldman Sachs Group Inc (GS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • CEFC China Energy Co Ltd：石油・ガス：M&Aディール及び事業提携情報
    Summary CEFC China Energy Co Ltd (CEFC China Energy) operates as energy and financial services provider. It is engaged in offering upstream oil and gas equities and interests. The company provides financial support with licenses. It is also engaged in investments and international banking businesses …
  • Galena Biopharma Inc (GALE)-医療機器分野：企業M&A・提携分析
    Summary Galena Biopharma Inc (Galena) is a biopharmaceutical company that develops and markets therapies for the treatment of unmet medical needs and advance care. The company's pipeline products comprise NeuVax, NeuVax Present, NeuVax Hercepti, NeuVax Vadis, GALE-401 and GALE-301 folate binding pro …
  • Sonic Healthcare Limited：企業のM&A・事業提携・投資動向
    Sonic Healthcare Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sonic Healthcare Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Yamaha Corporation：企業の戦略・SWOT・財務情報
    Yamaha Corporation - Strategy, SWOT and Corporate Finance Report Summary Yamaha Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Hanmi Pharmaceuticals Co Ltd (128940)：製薬・医療：M&Aディール及び事業提携情報
    Summary Hanmi Pharmaceuticals Co Ltd (Hanmi Pharma), a subsidiary of Hanmi Science Co Ltd is a developer of prescription drugs and over the counter drugs. The company’s prescription drugs include osteoporosis, antibiotics, antidiarrheal, liver supplements and antiemetics. It provides over the counte …
  • Riyad Bank：企業の戦略・SWOT・財務分析
    Riyad Bank - Strategy, SWOT and Corporate Finance Report Summary Riyad Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆